Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujie Lu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Functional Biomaterials|February 24, 2023
Magnetic Nanomaterials Mediate Electromagnetic Stimulations of Nerves for Applications in Stem Cell and Cancer TreatmentsLei Wang, Yefan Duan, Shujie Lu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 23, 2009
[Protective effect of hawthorn leaf procyanidins on cardiomyocytes of neonatal rats subjected to simulated ischemia-reperfusion injury]Peng Li, Jiannong Wang, Shujie Lu, et al.
BMC Medical Imaging|November 9, 2021
A NIM PET/CT phantom for evaluating the PET image quality of micro-lesions and the performance parameters of CTShujie Lu, Peng Zhang, Chengwei Li, et al.
Frontiers in Public Health|April 1, 2022
Genetic Algorithm for TMS Coil Position Optimization in Stroke TreatmentShujie Lu, Haoyu Jiang, Chengwei Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 2, 2024
Electrical Dissipation Factor Measurements of Droplet Impact-Derived Microgels with Different Topological StructuresLei Wang, Xuerong Ding, Yiheng Hu, et al.
Journal of Agricultural and Food Chemistry|February 19, 2025
Multistrategy Optimization for High-Yield 3-Fucosyllactose Production in <i>Escherichia coli</i> BL21 Star (DE3)Shujie Lu, Caiwen Lao, Jin Wang, et al.
BMJ Open Ophthalmology|January 6, 2026
Phase 1 dose-escalation study of IBI324, a VEGF-A/Ang-2 bispecific antibody, for the treatment of diabetic macular oedemaZilin Wang, Junran Sun, Kun Liu, et al.
American Journal of Ophthalmology|November 21, 2022
A Novel Bispecific Fusion Protein Targeting C3b/C4b and VEGF in Patients With nAMD: A Randomized, Open-Label, Phase 1b StudyHuixun Jia, Tong Li, Junran Sun, et al.
Science Translational Medicine|June 1, 2022
Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapyShiqi Yang, Tong Li, Huixun Jia, et al.
Ophthalmology Science|October 6, 2025
Efficacy and Safety of Efdamrofusp Alfa with Personalized Dosing Intervals in Neovascular Age-Related Macular Degeneration: A Phase II TrialTong Li, Shiqi Yang, Qinghuai Liu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Functional Biomaterials|February 24, 2023
Magnetic Nanomaterials Mediate Electromagnetic Stimulations of Nerves for Applications in Stem Cell and Cancer TreatmentsLei Wang, Yefan Duan, Shujie Lu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 23, 2009
[Protective effect of hawthorn leaf procyanidins on cardiomyocytes of neonatal rats subjected to simulated ischemia-reperfusion injury]Peng Li, Jiannong Wang, Shujie Lu, et al.
BMC Medical Imaging|November 9, 2021
A NIM PET/CT phantom for evaluating the PET image quality of micro-lesions and the performance parameters of CTShujie Lu, Peng Zhang, Chengwei Li, et al.
Frontiers in Public Health|April 1, 2022
Genetic Algorithm for TMS Coil Position Optimization in Stroke TreatmentShujie Lu, Haoyu Jiang, Chengwei Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 2, 2024
Electrical Dissipation Factor Measurements of Droplet Impact-Derived Microgels with Different Topological StructuresLei Wang, Xuerong Ding, Yiheng Hu, et al.
Journal of Agricultural and Food Chemistry|February 19, 2025
Multistrategy Optimization for High-Yield 3-Fucosyllactose Production in <i>Escherichia coli</i> BL21 Star (DE3)Shujie Lu, Caiwen Lao, Jin Wang, et al.
BMJ Open Ophthalmology|January 6, 2026
Phase 1 dose-escalation study of IBI324, a VEGF-A/Ang-2 bispecific antibody, for the treatment of diabetic macular oedemaZilin Wang, Junran Sun, Kun Liu, et al.
American Journal of Ophthalmology|November 21, 2022
A Novel Bispecific Fusion Protein Targeting C3b/C4b and VEGF in Patients With nAMD: A Randomized, Open-Label, Phase 1b StudyHuixun Jia, Tong Li, Junran Sun, et al.
Science Translational Medicine|June 1, 2022
Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapyShiqi Yang, Tong Li, Huixun Jia, et al.
Ophthalmology Science|October 6, 2025
Efficacy and Safety of Efdamrofusp Alfa with Personalized Dosing Intervals in Neovascular Age-Related Macular Degeneration: A Phase II TrialTong Li, Shiqi Yang, Qinghuai Liu, et al.
Pageof 2